Valuation : Repligen Corporation

Market Cap 9.46B 8.14B 7.66B 7B 13.09B 893B 13.12B 90.49B 35.11B 458B 35.52B 34.74B 1,476B P/E 2026 *
222x
P/E 2027 * 97x
Enterprise Value 9.22B 7.94B 7.47B 6.82B 12.76B 871B 12.8B 88.25B 34.25B 447B 34.64B 33.89B 1,440B EV / Sales 2026 *
11.2x
EV / Sales 2027 * 9.34x
Free-Float
94.32%
Yield 2026 *
-
Yield 2027 * -
1 day-1.19%
1 week-4.92%
Current month-7.39%
1 month+11.90%
3 months+32.44%
6 months+33.18%
Current year+2.28%
1 week 165
Extreme 165
182.57
1 month 156.08
Extreme 156.085
188.73
Current year 100.99
Extreme 100.99
188.73
1 year 100.99
Extreme 100.99
188.73
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Tax

Controller/Auditor

-277 0.0005%
8/20/26 Exercice

Chief Executive Officer

16,278 0.0288%
7/16/26 Sell

Chief Financial Officer

-530 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%-4.92%+38.99%-4.63% 9.57B
-0.42%-3.68%-18.43%+5.33% 188B
+1.15%+3.22%+1.42%+14.66% 119B
-1.86%+2.77%+13.07%+89.16% 64.35B
-1.31%-1.33%+23.64%+48.69% 52.59B
-1.54%-2.52%-3.41%-33.66% 51.11B
-2.02%-3.22%+8.84%-13.73% 33.85B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+37.34%-16.61% 24.12B
-1.44%-5.00%-7.60%+9.97% 23.39B
Average -0.94%-0.26%+10.43%+11.02% 59.85B
Weighted average by Cap. -0.57%-0.42%+0.01%+15.27%

Financials

2026 *2027 *
Net sales 827M 712M 670M 612M 1.14B 78.09B 1.15B 7.91B 3.07B 40.06B 3.11B 3.04B 129B 969M 833M 784M 716M 1.34B 91.45B 1.34B 9.27B 3.6B 46.92B 3.64B 3.56B 151B
Net income 41.92M 36.07M 33.94M 31M 58M 3.96B 58.16M 401M 156M 2.03B 157M 154M 6.54B 98.84M 85.05M 80.02M 73.1M 137M 9.33B 137M 946M 367M 4.79B 371M 363M 15.42B
Net Debt -234M -201M -189M -173M -323M -22.06B -324M -2.24B -867M -11.32B -877M -858M -36.46B -408M -351M -330M -302M -565M -38.52B -566M -3.9B -1.51B -19.77B -1.53B -1.5B -63.68B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-09-04 $167.60 -1.19% 806,065
26-09-03 $169.61 -1.93% 1,325,296
26-09-02 $172.94 +1.72% 959,331
26-09-01 $170.02 -6.06% 1,405,066
26-08-31 $180.98 +2.67% 790,973
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
167.60USD
Average target price
187.70USD
Spread / Average Target
+11.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock